File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1136/bmjopen-2021-048764
- Scopus: eid_2-s2.0-85117091078
- PMID: 34635517
Supplementary
- Citations:
- Appears in Collections:
Article: Protocol of a systematic review and network meta-analysis for the prevention and treatment of perinatal depression
| Title | Protocol of a systematic review and network meta-analysis for the prevention and treatment of perinatal depression |
|---|---|
| Authors | |
| Keywords | depression & mood disorders maternal medicine mental health |
| Issue Date | 11-Oct-2021 |
| Publisher | BMJ Publishing Group |
| Citation | BMJ Open, 2021, v. 11, n. 10, p. 1-6 How to Cite? |
| Abstract | Introduction: Perinatal depression is common and can often lead to adverse health outcomes for mother and child. Multiple pharmacological and non-pharmacological treatments have been evaluated against usual care or placebo controls in meta-analyses for preventing and treating perinatal depression compared. It is not yet established which of these candidate treatments might be the optimal approach for prevention or treatment. Methods and analysis: A systematic review and Bayesian network meta-analyses will be conducted. Eight electronic databases shall be searched for randomised controlled trials that have evaluated the effectiveness of treatments for prevention and/or treatment of perinatal depression. Screening of articles shall be conducted by two reviewers independently. One network meta-analysis shall evaluate the effectiveness of interventions in preventing depression during the perinatal period. A second network meta-analysis shall compare the effectiveness of treatments for depression symptoms in women with perinatal depression. Bayesian 95% credible intervals shall be used to estimate the pooled mean effect size of each treatment, and surface under cumulative ranking area will be used to rank the treatments' effectiveness. Ethics and dissemination: We shall report our findings so that healthcare providers can make informed decisions on what might be the optimal approach for addressing perinatal depression to prevent cases and improve outcomes in those suffering from depression through knowledge exchange workshops, international conference presentations and journal article publications. PROSPERO registration number: CRD42020200081. |
| Persistent Identifier | http://hdl.handle.net/10722/359396 |
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Smith, David Robert | - |
| dc.contributor.author | Hung, Sze Chai | - |
| dc.contributor.author | Goh, Joyce | - |
| dc.contributor.author | Ip, Hoi Lam | - |
| dc.contributor.author | Fong, Daniel Yee Tak | - |
| dc.contributor.author | Ali, Shehzad | - |
| dc.contributor.author | Wilson, Claire Anna | - |
| dc.contributor.author | Lok, Kris Yuet-Wan | - |
| dc.date.accessioned | 2025-09-03T00:30:14Z | - |
| dc.date.available | 2025-09-03T00:30:14Z | - |
| dc.date.issued | 2021-10-11 | - |
| dc.identifier.citation | BMJ Open, 2021, v. 11, n. 10, p. 1-6 | - |
| dc.identifier.uri | http://hdl.handle.net/10722/359396 | - |
| dc.description.abstract | <p>Introduction: Perinatal depression is common and can often lead to adverse health outcomes for mother and child. Multiple pharmacological and non-pharmacological treatments have been evaluated against usual care or placebo controls in meta-analyses for preventing and treating perinatal depression compared. It is not yet established which of these candidate treatments might be the optimal approach for prevention or treatment. <br></p><p>Methods and analysis: A systematic review and Bayesian network meta-analyses will be conducted. Eight electronic databases shall be searched for randomised controlled trials that have evaluated the effectiveness of treatments for prevention and/or treatment of perinatal depression. Screening of articles shall be conducted by two reviewers independently. One network meta-analysis shall evaluate the effectiveness of interventions in preventing depression during the perinatal period. A second network meta-analysis shall compare the effectiveness of treatments for depression symptoms in women with perinatal depression. Bayesian 95% credible intervals shall be used to estimate the pooled mean effect size of each treatment, and surface under cumulative ranking area will be used to rank the treatments' effectiveness.<br></p><p> Ethics and dissemination: We shall report our findings so that healthcare providers can make informed decisions on what might be the optimal approach for addressing perinatal depression to prevent cases and improve outcomes in those suffering from depression through knowledge exchange workshops, international conference presentations and journal article publications. <br></p><p>PROSPERO registration number: CRD42020200081.</p> | - |
| dc.language | eng | - |
| dc.publisher | BMJ Publishing Group | - |
| dc.relation.ispartof | BMJ Open | - |
| dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
| dc.subject | depression & mood disorders | - |
| dc.subject | maternal medicine | - |
| dc.subject | mental health | - |
| dc.title | Protocol of a systematic review and network meta-analysis for the prevention and treatment of perinatal depression | - |
| dc.type | Article | - |
| dc.identifier.doi | 10.1136/bmjopen-2021-048764 | - |
| dc.identifier.pmid | 34635517 | - |
| dc.identifier.scopus | eid_2-s2.0-85117091078 | - |
| dc.identifier.volume | 11 | - |
| dc.identifier.issue | 10 | - |
| dc.identifier.spage | 1 | - |
| dc.identifier.epage | 6 | - |
| dc.identifier.eissn | 2044-6055 | - |
| dc.identifier.issnl | 2044-6055 | - |
